我国制药企业药品不良反应报告比例偏低的原因分析

目的：促进我国制药企业的药品不良反应报告和监测，完善我国药品不良反应监测体系，促进药品安全。方法：通过国内外对比，分析我国制药企业报告比例偏低的原因。结果与结论：应树立正确的认识，完善相关法律、法规，并加强药品安全责任体系建设。

Analysis on the reasons for domestic pharmaceutical enterprises for relatively lower reporting proportion of adverse drug reaction

Objective ： To promote domestic pharmaceutical enterprises＇ reporting and monitoring of adverse drug reaction （ADR） ,improve domestic monitoring system on this aspect, and promote drug safety. Methods： The reasons for domestic pharmaceutical enterprises＇ relatively lower reporting proportion of ADR was analyzed through domestic and interuational comparisons. Results and Conclusion： Correct ideas must be set up in order to improve related laws and regulations, and the construction of surveillance system for drug safety must be strengthened.